[Gly22 ]- Amyloid beta 1-40 Arctic human,> = 95% (HPLC)

Code: scp0029-1mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Amino Acid Sequence

Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Va...


en savoir plus

Votre prix
£325.00 1MG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Amino Acid Sequence

Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val

General description

β-Amyloid peptides are the major constituents of senile plaques and neurofibrillary tangles that occur in the hippocampus, neocortex, and amygdala of patients with Alzheimer′s disease. Aβ (1-40) whether soluble or insoluble differentiates AD vs high pathology controls. The Arctic mutation E22G causes early onset of Alzheimer′s compared to wild type and promotes protofibril formation and neurotoxicity.

assay≥95% (HPLC)
compositionPeptide Content, ≥75%
formlyophilized
Gene Informationhuman ... APP(351)
storage conditionprotect from light
storage temp.−20°C
UniProt accession no.P05067
Code
Description
Unité de vente
Prix annoncé
Qté
SCP0029-500UG
Unité:500UG
Prix annoncé: £240.00
Source:Prix annoncé
Ce produit répond aux critères suivants: